Home
Diseases
PBC
News

News Related to PBC

Related coverage linked through entity extraction aliases.

GSK Licenses Linerixibat to Alfasigma for $690M; Eisai's E2086 Receives Orphan Designation

Mar 09, 2026

GSK agreed to license linerixibat to Alfasigma in a deal worth up to $690 million, while Eisai received orphan drug designation in Japan for E2086, a novel selective orexin 2 receptor agonist for narcolepsy.

FDA Drug Approval Decisions Expected in March 2026

Feb 13, 2026

The FDA is set to make approval decisions on five drug applications in March 2026, including treatments for psoriatic arthritis, dry eye disease, hypothalamic obesity, cholestatic pruritus, and a rare genetic disorder.